Oak Street Health, Inc.
OSH was delisted on the 1st of May, 2023.
0 hedge funds and large institutions have $0 invested in Oak Street Health, Inc. in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $8.5M → $0 (-$8.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
-$8.5M |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$2.46K |
OSH Hedge Fund Activity: Q3 2023 in Review
0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Oak Street Health, Inc. (OSH) for Q3 2023, worth a combined $0 — down 100% from $8.5M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of OSH and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS AM, exiting entirely with an estimated $8.5M sold.
- 0 institutional investors held Oak Street Health, Inc. (OSH) as of Q3 2023, down from 2 in Q2 2023.
- Funds reported $0 of Oak Street Health, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Oak Street Health, Inc. positions in Q3 2023 and 2 closed out, a net change of -2 holders.
- The largest Oak Street Health, Inc. seller in Q3 2023 was UBS AM, an estimated $8.5M sold.
Based on aggregated 13F filings for Q3 2023.